Stephen Hoffman

Stephen Hoffman

Directeur/Membre du Conseil chez RESEARCH ALLIANCE CORP. II

Fortune : 7 229 $ au 31/05/2026

72 ans
Health Technology
Finance
Consumer Services

Profil

Stephen J.
Hoffman
was the founder of Somatogen, Inc., founded in 1987, where the title held was Vice President-Science & Technology from 1987 to 1990.
Current jobs include Chairman at Apic Bio, Inc. since 2021; Independent Director at Research Alliance Corp.
II since 2021; Independent Director at Talphera, Inc. since 2010; Director at Implicit Bioscience Ltd. since 2022; Director at Receptor Life Sciences, Inc. since 2021; and Director at BYOMass, Inc. since 2021.
Former jobs include Chief Executive Officer & Director at Aerpio Therapeutics LLC; Chief Executive Officer & Director at Aerpio Pharmaceuticals, Inc. from 2017 to 2019; Chairman at Bicycle Therapeutics Plc from 2016 to 2019; Chairman at Allos Therapeutics, Inc. from 2002 to 2012; Chairman at Anchiano Therapeutics Ltd. from 2018 to 2019; Director at Danforth Advisors LLC from 2020 to 2021; Director at Sirtris Pharmaceuticals, Inc. from 2004 to 2008; Non-Executive Director at Hovione Farmaciência SA; Managing Director at Skyline Management LLC from 2007 to 2014; Independent Director at Genocea Biosciences, Inc. from 2013 to 2017; Director at Concert Pharmaceuticals, Inc.; Director at KAI Pharmaceuticals, Inc.; Director at Proteon Therapeutics, Inc.; Independent Director at Dicerna Pharmaceuticals, Inc. from 2007 to 2021; Director at Helomics Corp.; Director at Tolerx, Inc.; Director at PPD Dermatology LLC; Director at Sutro Biopharma, Inc.; Director at Palleon Pharmaceuticals, Inc.; Director at Collegium Pharmaceutical, Inc.; Vice President-Science & Technology at Baxter International, Inc. from 1987 to 1990; General Partner at TVM Capital GmbH from 2003 to 2007; and General Partner at TVM Capital Corp.
from 2003 to 2007.
Education includes doctorate degrees from Northwestern University and The University of Colorado School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
24/04/2026 8 859 ( 0,02 % ) 7 229 $ 31/05/2026

Postes actifs de Stephen Hoffman

SociétésPosteDébut
TALPHERA, INC. Directeur/Membre du Conseil 01/02/2010
RESEARCH ALLIANCE CORP. II Directeur/Membre du Conseil 01/03/2021
Directeur/Membre du Conseil 01/10/2022
Directeur/Membre du Conseil 27/10/2021
Directeur/Membre du Conseil 18/03/2021
Président 05/01/2021

Anciens postes connus de Stephen Hoffman

SociétésPosteFin
DICERNA PHARMACEUTICALS, INC. Directeur/Membre du Conseil 28/12/2021
Directeur/Membre du Conseil 01/12/2021
Directeur/Membre du Conseil 01/11/2020
░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Stephen Hoffman

Formation de Stephen Hoffman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Finance

Consumer Services

Health Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Finance

  1. Bourse
  2. Insiders
  3. Stephen Hoffman
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇